Optimizing Vancomycin Exposure for Early Treatment Response in Very-Low-Birth-Weight Neonates With Late-Onset Sepsis
{{output}}
Background: Vancomycin is widely used to treat neonatal late-onset sepsis (LOS). However, its optimal pharmacokinetic/pharmacodynamic targets in neonates, particularly those with very low birth weight (VLBW), remain inadequately ... ...
